<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR17">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Attal</surname>
    <given-names>Michel</given-names>
   </name>
   <name>
    <surname>Palumbo</surname>
    <given-names>Antonio</given-names>
   </name>
   <name>
    <surname>Holstein</surname>
    <given-names>Sarah A.</given-names>
   </name>
   <name>
    <surname>Lauwers-Cances</surname>
    <given-names>Valerie</given-names>
   </name>
   <name>
    <surname>Petrucci</surname>
    <given-names>Maria Teresa</given-names>
   </name>
   <name>
    <surname>Richardson</surname>
    <given-names>Paul G.</given-names>
   </name>
   <name>
    <surname>Hulin</surname>
    <given-names>Cyrille</given-names>
   </name>
   <name>
    <surname>Tosi</surname>
    <given-names>Patrizia</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>Kenneth Carl</given-names>
   </name>
   <name>
    <surname>Caillot</surname>
    <given-names>Denis</given-names>
   </name>
   <name>
    <surname>Magarotto</surname>
    <given-names>Valeria</given-names>
   </name>
   <name>
    <surname>Moreau</surname>
    <given-names>Philippe</given-names>
   </name>
   <name>
    <surname>Marit</surname>
    <given-names>Gerald</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>Zhinuan</given-names>
   </name>
   <name>
    <surname>McCarthy</surname>
    <given-names>Philip L.</given-names>
   </name>
  </person-group>
  <article-title>Lenalidomide (LEN) maintenance (MNTC) after high-dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta-analysis (MA) of overall survival (OS)</article-title>
  <source>Journal of Clinical Oncology</source>
  <year>2016</year>
  <volume>34</volume>
  <issue>15_suppl</issue>
  <fpage>8001</fpage>
  <lpage>8001</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2016.34.15_suppl.8001</pub-id>
 </element-citation>
</ref>
